L1CAM and neoplasm: Forty nine (53%) tumours were classified as L1CAM positive, similar to the 47% positive cases in the Italian cohort and significantly associated with non‐endometrioid histology, high‐grade, advanced age and reduced response to platinum‐based chemotherapy treatment (Table 2).